Your support changes lives. Thank you!
Learn More
In this ADAA 2026 conference presentation, Dr. Berra Yazar-Klosinski, along with Dr. Jill Emanuele, Dr. Jonathan Schettino, Dr. Azin Bekhrad, and Kari Gregory, discussed the current state of psychedelic-assisted therapy, including emerging research, clinical applications, training pathways, and important considerations for mental health professionals.
Interest in psychedelic-assisted therapies has grown rapidly as researchers explore new treatment options for conditions such as PTSD and treatment-resistant depression.
The presenters reviewed evidence related to compounds such as psilocybin and MDMA, explored similarities and differences between psychedelic-assisted therapies and traditional evidence-based treatments, and addressed ongoing questions surrounding safety, effectiveness, regulation, and clinician training. Attendees gained practical insights into navigating this rapidly evolving area of mental health care and research.
Recorded by Vumedi in partnership with ADAA.
ADAA Continuing Education Credits for Live and On-Demand Programming
Learners complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Some ADAA professional webinars focused on diversity or cultural competency subject matter are eligible for the Cross-Culture Competency Diversity Credit. If a webinar is eligible for this credit, it will be reflected on your credit certificate.
All continuing education credits are provided through Amedco, LLC. Learn more about the CE/CME accreditation information here.